Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Mateo

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Breast Cancer Research and Treatment|March 9, 2016
Study of breast cancer incidence in patients of lymphangioleiomyomatosisOlivier Nuñez, Antonio Román, Simon R Johnson, et al.
Genome Medicine|February 3, 2024
Biological basis of extensive pleiotropy between blood traits and cancer riskMiguel Angel Pardo-Cea, Xavier Farré, Anna Esteve, et al.
Cancer Research|March 11, 2025
Harnessing STING Signaling and Natural Killer Cells Overcomes PARP Inhibitor Resistance in Homologous Recombination-Deficient Breast CancerFlaminia Pedretti, Mohmed Abdalfttah, Benedetta Pellegrino, et al.
Nucleic Acids Research|September 12, 2023
RNF8 ubiquitylation of XRN2 facilitates R-loop resolution and restrains genomic instability in BRCA1 mutant cellsRehna Krishnan, Mariah Lapierre, Brandon Gautreau, et al.
Human Mutation|August 22, 2021
Altered regulation of BRCA1 exon 11 splicing is associated with breast cancer risk in carriers of BRCA1 pathogenic variantsGorka Ruiz de Garibay, Ignacio Fernandez-Garcia, Sylvie Mazoyer, et al.
Plos One|November 13, 2018
Correction: Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell StemnessGorka Ruiz de Garibay, Carmen Herranz, Alicia Llorente, et al.
Plos One|July 14, 2015
Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell StemnessGorka Ruiz de Garibay, Carmen Herranz, Alicia Llorente, et al.
NAR Cancer|March 10, 2025
Harnessing transcriptional regulation of alternative end-joining to predict cancer treatmentRoderic Espín, Ferran Medina-Jover, Javier Sigüenza-Andrade, et al.
EMBO Molecular Medicine|August 11, 2021
Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosisCarmen Herranz, Francesca Mateo, Alexandra Baiges, et al.
ERJ Open Research|June 30, 2026
Exploring glucocorticoid receptor signalling in lymphangioleiomyomatosisAlexandra Baiges, Lara Ruiz-Auladell, Irene García, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Breast Cancer Research and Treatment|March 9, 2016
Study of breast cancer incidence in patients of lymphangioleiomyomatosisOlivier Nuñez, Antonio Román, Simon R Johnson, et al.
Genome Medicine|February 3, 2024
Biological basis of extensive pleiotropy between blood traits and cancer riskMiguel Angel Pardo-Cea, Xavier Farré, Anna Esteve, et al.
Cancer Research|March 11, 2025
Harnessing STING Signaling and Natural Killer Cells Overcomes PARP Inhibitor Resistance in Homologous Recombination-Deficient Breast CancerFlaminia Pedretti, Mohmed Abdalfttah, Benedetta Pellegrino, et al.
Nucleic Acids Research|September 12, 2023
RNF8 ubiquitylation of XRN2 facilitates R-loop resolution and restrains genomic instability in BRCA1 mutant cellsRehna Krishnan, Mariah Lapierre, Brandon Gautreau, et al.
Human Mutation|August 22, 2021
Altered regulation of BRCA1 exon 11 splicing is associated with breast cancer risk in carriers of BRCA1 pathogenic variantsGorka Ruiz de Garibay, Ignacio Fernandez-Garcia, Sylvie Mazoyer, et al.
Plos One|November 13, 2018
Correction: Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell StemnessGorka Ruiz de Garibay, Carmen Herranz, Alicia Llorente, et al.
Plos One|July 14, 2015
Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell StemnessGorka Ruiz de Garibay, Carmen Herranz, Alicia Llorente, et al.
NAR Cancer|March 10, 2025
Harnessing transcriptional regulation of alternative end-joining to predict cancer treatmentRoderic Espín, Ferran Medina-Jover, Javier Sigüenza-Andrade, et al.
EMBO Molecular Medicine|August 11, 2021
Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosisCarmen Herranz, Francesca Mateo, Alexandra Baiges, et al.
ERJ Open Research|June 30, 2026
Exploring glucocorticoid receptor signalling in lymphangioleiomyomatosisAlexandra Baiges, Lara Ruiz-Auladell, Irene García, et al.
Pageof 5